Results 141 to 150 of about 55,687 (218)

Targeting GALNT7 Disrupts the TAZ O-GalNAcylation Feedback Loop to Suppress Gallbladder Cancer Progression. [PDF]

Adv Sci (Weinh)
Qiu P, Zhang M, Feng Y, Deng Y, Zhao K, Li X, Lu Y, Tian L, Yang T, Yao W, Wang J, Deng Z.   +11 more
europepmc   +1 more source

Erratum: [Corrigendum] MicroRNA-182 promotes epithelial-mesenchymal transition by targeting FOXN3 in gallbladder cancer. [PDF]

Oncol Lett
Zhang J, Hu Z, Wen C, Liao Q, He B, Peng J, Tang X, Chen Z, Xie Y.   +8 more
europepmc   +1 more source

Protein Expression Analysis and Functional Characterization of Sorcin in Gallbladder Cancer. [PDF]

Cells
Jain V, Saklani N, Kawatra S, Sakhuja P, Goyal S, Agarwal AK, Kumar P, Siraj F, Gautam P.   +8 more
europepmc   +1 more source

Temporal trends in the incidence and prognosis of lung metastasis in gallbladder cancer: risk stratification and survival analysis. [PDF]

Am J Cancer Res
Yu Y, Li X, Hui JJ, Li D.
europepmc   +1 more source

Development and Validation of Nomogram Predicting Survival in Resectable Gallbladder Cancer. [PDF]

J Hepatobiliary Pancreat Sci
Patkar S, Shah TM, Kazi M, Kannan S, Varty G, Ostwal V, Ramaswamy A, Bhargav P, Barve P, Goel M.   +9 more
europepmc   +1 more source

Urinary bladder invasion secondary to dissemination of gallbladder cancer: an unusual presentation. [PDF]

Clin J Gastroenterol
Watanabe R, Koshitani T, Hashidume S, Kasho K, Yokomura A, Takihara H, Takemoto T, Itoh M, Nakajima N.   +8 more
europepmc   +1 more source

Gallbladder cancer presenting with a single giant common bile duct stone in a patient with normal cholestatic function tests: a case report. [PDF]

Oxf Med Case Reports
Shibiru YA, Nigussie S, Yegnanew A, Moges DD.   +3 more
europepmc   +1 more source

Perspectives and preferences on palliative chemotherapy-immunotherapy in gallbladder cancer patients. [PDF]

Ecancermedicalscience
Dora KA, Rajashekhar V, Kaushik MR, Vora G, Sarin A, Patel A.   +5 more
europepmc   +1 more source